Previously, several studies have reported the relationship between UGP2 and the occurrence and development of several tumours, including pancreatic ductal carcinoma [12], gallbladder cancer [13], colorectal cancer [14], acute myeloid leukaemia [15], and glioma [16]. Here, UGP2 is linked to pancreatic ductal adenocarcinoma.